Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion

Medicine and Dentistry

• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Protein 50%
• Receptor 50%
• Glycoprotein 50%
• Vaccine 50%
• Angiotensin Converting Enzyme 2 50%
• Development 25%
• Evaluation Study 25%
• Infection 25%
• Immune Response 25%
• Epitope 25%
• Immune Evasion 25%
• Death 25%
• Binding Affinity 25%
• Fitness 25%
• B Cell 25%
• Neutralizing Antibody 25%
• COVID-19 25%
• Vitronectin 25%